International Rare Disease Consultation

thcare professionals to identify the most important unanswered research questions. A steering group of 20 international stakeholders, half of whom will be people with lived experience of rare diseases or their advocates will define the project’s scope. The PSP will take a broad, inclusive view, gath

ering research priorities from people of all ages and from low-, middle-, and high income countries